|
|
You are not alone. The IMF is here to help everyone battling multiple myeloma—patients, families, friends, caregivers and the medical and scientific communities. How can we help you today ? |
|
|
| 09.11.09 |
|
Study of Vorinostat (MK0683) an HDAC Inhibitor, or Placebo in Combination with Bortezomib in Patients with Multiple Myeloma
|
|
Merck-sponsored multi-national study in patients with relapsed or refractory multiple myeloma
|
|
|
|
| |
 |
|
|
| 09.11.09 |
|
Study of Vorinostat (MK0683), an HDAC Inhibitor, in Combination with Bortezomib in Patients with Relapsed or Refractory Multiple Myeloma
|
|
Merck-sponsored multi-national study in patients with relapsed or refractory multiple myeloma after at least 2 prior treatment regimens.
|
|
|
|
| |
|
|
|
|
|
